Differences in survival outcome between stage I and stage II glottic cancer: A SEER-based analysis.

Related Articles

Differences in survival outcome between stage I and stage II glottic cancer: A SEER-based analysis.

Laryngoscope. 2015 Sep;125(9):2093-8

Authors: Chen JJ, Stessin A, Christos P, Wernicke AG, Nori D, Parashar B

Abstract
OBJECTIVE: The purpose of this study was to investigate and compare the cause-specific survival (CSS) of stage I (tumor [T]1 node [N]0 metastasis [M]0) versus stage II (T2N0M0) glottic cancer in a large population cohort.
STUDY DESIGN: We analyzed data from the Surveillance, Epidemiology, and End Results 18 database from 1973 to 2009, comprising patients diagnosed with T1N0M0 or T2N0M0 squamous cell glottic cancer. Kaplan-Meier survival analysis, multivariable Cox proportional hazards regression analysis, and competing-risks survival regression were used for statistical analysis.
RESULTS: There were 4,422 patients who met all inclusion criteria. The 36-month CSS was 93.9% for stage I verus 86.5% for stage II, with P < 0.0001. Stage II status conferred a 2.494 hazard ratio for increased risk of cause-specific death compared to stage I.
CONCLUSIONS: Stage II glottic cancers have a significantly worse prognosis and may need a different approach to management than stage I tumors.
LEVEL OF EVIDENCE: 4.

PMID: 26109043 [PubMed - indexed for MEDLINE]

from #ENT-PubMed via ola Kala on Inoreader http://ift.tt/1ktzNJb
via IFTTT